Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
VRTX

Vertex

$172.78

-3.14 (-1.78%)

15:30
08/15/18
08/15
15:30
08/15/18
15:30
Hot Stocks
Vertex announces FDA approval of KALYDECO to include use in children with CF »

Vertex announced the U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

  • 31

    Aug

TORC

ResTORbio

$10.40

-0.97 (-8.53%)

, VRTX

Vertex

$175.92

0.8 (0.46%)

08:05
08/15/18
08/15
08:05
08/15/18
08:05
Hot Stocks
ResTORbio names Vertex executive Jeffrey Chodakewitz to board »

resTORbio (TORC)…

TORC

ResTORbio

$10.40

-0.97 (-8.53%)

VRTX

Vertex

$175.92

0.8 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

  • 31

    Aug

Over a week ago
GLPG

Galapagos NV

$113.02

1.18 (1.06%)

16:47
08/09/18
08/09
16:47
08/09/18
16:47
Downgrade
Galapagos NV rating change  »

Galapagos NV downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSM

Insmed

$24.38

(0.00%)

, AZN

AstraZeneca

$38.89

0.62 (1.62%)

07:40
08/08/18
08/08
07:40
08/08/18
07:40
Recommendations
Insmed, AstraZeneca, Gilead, Vertex analyst commentary at H.C. Wainwright »

Insmed likely to be…

INSM

Insmed

$24.38

(0.00%)

AZN

AstraZeneca

$38.89

0.62 (1.62%)

GILD

Gilead

$78.39

0.53 (0.68%)

VRTX

Vertex

$177.51

2.49 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

  • 25

    Aug

  • 30

    Aug

  • 31

    Aug

  • 28

    Sep

ELOX

Eloxx Pharmaceuticals

$13.32

-0.08 (-0.60%)

, VRTX

Vertex

$177.51

2.49 (1.42%)

20:28
08/07/18
08/07
20:28
08/07/18
20:28
Recommendations
Eloxx Pharmaceuticals, Vertex analyst commentary at Piper Jaffray »

Eloxx Pharma's…

ELOX

Eloxx Pharmaceuticals

$13.32

-0.08 (-0.60%)

VRTX

Vertex

$177.51

2.49 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 30

    Aug

  • 31

    Aug

VRTX

Vertex

$177.40

2.38 (1.36%)

15:50
08/07/18
08/07
15:50
08/07/18
15:50
Hot Stocks
Vertex announces FDA approval of ORKAMBI to treat cystic fibrosis »

Vertex announced the U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

  • 31

    Aug

GLPG

Galapagos NV

$108.81

4.56 (4.37%)

09:18
08/07/18
08/07
09:18
08/07/18
09:18
Recommendations
Galapagos NV analyst commentary at Credit Suisse »

Galapagos NV price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRTX

Vertex

$175.02

0.5 (0.29%)

08:04
08/07/18
08/07
08:04
08/07/18
08:04
Initiation
Vertex initiated at Stifel »

Vertex transferred with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Aug

  • 31

    Aug

VRTX

Vertex

$171.86

-4.09 (-2.32%)

10:31
07/27/18
07/27
10:31
07/27/18
10:31
Recommendations
Vertex analyst commentary at Piper Jaffray »

Piper says Vertex faces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRTX

Vertex

$171.56

-4.39 (-2.50%)

10:26
07/27/18
07/27
10:26
07/27/18
10:26
Hot Stocks
CHMP adopts positive opinion on Symkevi »

The EMA announced earlier…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.